Novel Coronavirus Pneumonia Clinical Trial
Official title:
The Observational Study of Cardiac and Pulmonary Ultrasound and Evaluation of Treatment of Severe Patients With Novel Coronavirus Pneumonia
Complete the examination of cardio-pulmonary ultrasound in accordance with the a-ccue process of patients with novel coronavirus bedside. To summarize and analyze the characteristics of cardiopulmonary ultrasound in patients with novel coronavirus pneumonia, and assess the relationship between pulmonary ultrasound imaging score and National Early Warning Score(NEWS) and prognosis. Auto line B is a method which is based on artificial intelligence is used to calculate the lungs ultrasonic B line numbers reviewing the status of patients with lung, and also evaluate patients' lungs using the traditional artificial semi-quantitative method, to evaluate those two kinds of evaluation methods for the evaluation of patients with lung condition effects are consistent or not, and verify consistency of ultrasonic evaluation method and the way of CT evaluation.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT04798716 -
The Use of Exosomes for the Treatment of Acute Respiratory Distress Syndrome or Novel Coronavirus Pneumonia Caused by COVID-19
|
Phase 1/Phase 2 | |
| Completed |
NCT05305456 -
Clinical Trial Scheme of Tanreqing Capsules in the Treatment of COVID-19
|
Phase 3 | |
| Recruiting |
NCT04282902 -
A Study to Evaluate the Efficacy and Safety of Pirfenidone With Novel Coronavirus Infection
|
Phase 3 | |
| Withdrawn |
NCT04285190 -
The Effect of T89 on Improving Oxygen Saturation and Clinical Symptoms in Patients With COVID-19
|
N/A | |
| Recruiting |
NCT04283396 -
Study for Novel Coronavirus Pneumonia (NCP)
|
||
| Active, not recruiting |
NCT04273763 -
Evaluating the Efficacy and Safety of Bromhexine Hydrochloride Tablets Combined With Standard Treatment/ Standard Treatment in Patients With Suspected and Mild Novel Coronavirus Pneumonia (COVID-19)
|
N/A | |
| Completed |
NCT04280224 -
NK Cells Treatment for COVID-19
|
Phase 1 | |
| Completed |
NCT04273321 -
Efficacy and Safety of Corticosteroids in COVID-19
|
N/A | |
| Enrolling by invitation |
NCT04365309 -
Protective Effect of Aspirin on COVID-19 Patients
|
Phase 2/Phase 3 | |
| Completed |
NCT04645407 -
Effects of Fuzheng Huayu Tablets on COVID-19
|
Phase 4 |